Search results
Results from the WOW.Com Content Network
The New England Journal of Medicine published two editorials in 2003 expressing concern about off-label uses of HGH and the proliferation of advertisements for "HGH-Releasing" dietary supplements, and emphasized that there is no evidence that use of HGH in healthy adults or in geriatric patients is safe and effective – and especially emphasized that risks of long-term HGH treatment are unknown.
Attempts to create a wholly synthetic HGH failed. Limited supplies of HGH resulted in the restriction of HGH therapy to the treatment of idiopathic short stature. [79] Very limited clinical studies of growth hormone derived from an Old World monkey, the rhesus macaque, were conducted by John C. Beck and colleagues in Montreal, in the late 1950s ...
Late-night alcohol has a sedative effect because it disrupts the brain’s natural stages of sleep. And that affects the brain’s ability to support better health and memory .
Controversies regarding the use of human growth hormone (HGH) as treatment method have centered on the claims, products, and businesses related to the use of growth hormone as an anti-aging therapy. Most of these controversies fall into two categories: [citation needed]
After a busy morning, lunch can feel like just the pick-me-up you need — but sometimes the meal you thought would energize you is the very thing that makes you want to nap at your desk.
Tesamorelin, [11] under the trade name Egrifta, received U.S. Food and Drug Administration approval in 2010 for the treatment of lipodystrophy in HIV patients under highly active antiretroviral therapy, [12] and, in 2011, was investigated for effects on certain cognitive tests in the elderly. [13]
It could have a positive or negative impact on sleep, so the best time to take Lexapro depends on how it effects you. Plus, potential side effects of Lexapro.
Saizen is a commercial preparation of synthetic somatropin (growth hormone, a.k.a. GH) used for growth hormone treatment.Manufactured by Merck Serono, Saizen is produced by recombinant DNA technology from a mammalian cell line (mouse C127) that was modified by the addition of the human GH gene, resulting in an identical 191-amino acid sequence and structure.